Skip to main content
. Author manuscript; available in PMC: 2015 Oct 1.
Published in final edited form as: J Orthop Res. 2014 Jul 1;32(10):1349–1355. doi: 10.1002/jor.22671

Table 4.

Comparison of key cytokines and growth factors in APS from OA patients and control donors. ND = nondetectible concentration of cytokine using ELISA assays. NA = not available due to non-detectible concentration of cytokine in whole blood.

Cytokine Baseline Concentration APS Concentration (pg/ml) Fold Increase
IL-1ra Control (n = 92) 6,300 ± 3,000 39,000 ± 20,000 6.6
OA (n = 99) 7,600 ± 2,500 42,000 ± 20,000 5.9
sIL-IRII Control (n = 51) 10,000 ± 2,500 21,000 ± 5,000 2.1
OA (n = 99) 9,500 ± 2,500 21,000 ± 6,300 2.2
sTNF-RI Control (n = 53) 650 ± 490 2,100 ± 570 3.7
OA (n = 99) 810 ± 280 3,000 ± 960 3.9
sTNF-RII Control (n = 64) 1,000 ± 360 4,200 ± 1,500 4
OA (n = 99) 1,500 ± 490 5,100 ± 1,900 3.5
IL-1β Control (n = 56) 2.7 ± 1.2 7.2 ± 3.1 3
OA (n = 99) 3.3 ± 1.1 8.9 ± 7.3 2.8
TNFα Control (n = 26) ND 1.7 ± 0.8 NA
OA (n = 85) ND 4.3 ± 3.0 NA
IGF-1 Control (n = 48) 34,000 ± 37,000 52,000 ± 60,000 1.5
OA (n = 98) 79,000 ± 22,000 120,000 ± 43,000 1.5